Copyright  2003 limsoon wong Diagnosis of Childhood Acute Lymphoblastic Leukemia and Optimization of Risk-Benefit Ratio of Therapy Limsoon Wong Institute.

Slides:



Advertisements
Similar presentations
Instance-based Classification Examine the training samples each time a new query instance is given. The relationship between the new query instance and.
Advertisements

ECSI case Fall 2014 Andrea M. Sheehan, MD Associate Professor of Pathology & Immunology Baylor College of Medicine.
E2A and acute lymphoblastic leukemias (ALL). A closer look at the E2A gene... Other names: TCF3, ITF1, and Factors E12/E47 Located on chromosome 19 Encodes.
Copyright © 2004 by Limsoon Wong Research & Discovery: Technologies Today for Solving Problems Tomorrow Limsoon Wong Institute for Infocomm Research.
Bio277 Lab 2: Clustering and Classification of Microarray Data Jess Mar Department of Biostatistics Quackenbush Lab DFCI
Classification: Support Vector Machine 10/10/07. What hyperplane (line) can separate the two classes of data?
Classification of Microarray Data. Sample Preparation Hybridization Array design Probe design Question Experimental Design Buy Chip/Array Statistical.
Classification of Microarray Data. Sample Preparation Hybridization Array design Probe design Question Experimental Design Buy Chip/Array Statistical.
Genetic Testing in Genomic Medicine Gail H. Vance M.D. Professor, Department of Medical & Molecular Genetics Indiana University School of Medicine.
Gene Expression Based Tumor Classification Using Biologically Informed Models ISI 2003 Berlin Claudio Lottaz und Rainer Spang Computational Diagnostics.
SIMPLISTIC CLASSIFICATION OF LYMPHOID LEUKEMIAS
Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Kevin Paiz-Ramirez.
JAVED KHAN ET AL. NATURE MEDICINE – Volume 7 – Number 6 – JUNE 2001
Microarray Gene Expression Data Analysis A.Venkatesh CBBL Functional Genomics Chapter: 07.
Exciting Bioinformatics Adventures Limsoon Wong Institute for Infocomm Research.
Classification of multiple cancer types by multicategory support vector machines using gene expression data.
Whole Genome Expression Analysis
Challenges and Considerations in Linking Adult and Pediatric Leukemias David G. Poplack M.D. Texas Children’s Cancer Center Baylor College of Medicine.
Products of haematopoiesis. Leukaemia, the current hypothesis Defect in maturation of white blood cells-may involve a block in differentiation and/or.
Conclusions We have developed a robust, quality controlled, sensitive method for MRD assessment in precursor B cell ALL which can be replicated in a multi.
The acute Leukemias are clonal hematopoietic malignant disease that arise from the malignant T r a n s f o r m a t i o n of an early Hematopoietic stem.
Structured Analysis of Microarrays & Differential Coexpression Claudio Lottaz, Dennis Kostka & Rainer Spang Courses in Practical DNA Microarray Analysis.
Knowledge Discovery in Biomedicine Limsoon Wong Institute for Infocomm Research.
Copyright  2003 limsoon wong Data Mining of Gene Expression Profiles for the Diagnosis and Understanding of Diseases Limsoon Wong Institute for Infocomm.
Analysis and Management of Microarray Data Dr G. P. S. Raghava.
Exagen Diagnostics, Inc., all rights reserved Biomarker Discovery in Genomic Data with Partial Clinical Annotation Cole Harris, Noushin Ghaffari.
DR. YETUNDE T. ISRAEL-AINA PAEDIATRICIAN, UNIVERSITY OF BENIN TEACHING HOSPITAL, BENIN CITY BENIN BLOOD AND MARROW TRANSPLANT WORKSHOP, UNIVERSITY OF BENIN.
Copyright  2004 limsoon wong CS2220: Computation Foundation in Bioinformatics Limsoon Wong Institute for Infocomm Research Lecture slides for 3 February.
Selection of Patient Samples and Genes for Disease Prognosis Limsoon Wong Institute for Infocomm Research Joint work with Jinyan Li & Huiqing Liu.
Dose Interruption/Reduction of Tyrosine Kinase Inhibitors in the First 3 Months of Treatment of CML Is Associated with Inferior Early Molecular Responses.
Wang Y 1,2, Damaraju S 1,3,4, Cass CE 1,3,4, Murray D 3,4, Fallone G 3,4, Parliament M 3,4 and Greiner R 1,2 PolyomX Program 1, Department.
Using Emerging Patterns to Analyze Gene Expression Data Jinyan Li BioComputing Group Knowledge & Discovery Program Laboratories for Information Technology.
Knowledge Discovery from Biological and Clinical Data: BASIC BACKGROUND.
PCA, Clustering and Classification by Agnieszka S. Juncker Part of the slides is adapted from Chris Workman.
Enabling Reproducible Gene Expression Analysis Using Biological Pathways Limsoon Wong 7 April 2011 (Joint work with Donny Soh, Difeng Dong, Yike Guo)
CZ5225: Modeling and Simulation in Biology Lecture 8: Microarray disease predictor-gene selection by feature selection methods Prof. Chen Yu Zong Tel:
Gene Expression Signatures for Prognosis in NSCLC, Coupled with Signatures of Oncogenic Pathway Deregulation, Provide a Novel Approach for Selection of.
Copyright  2003 limsoon wong From Informatics to Bioinformatics: The Knowledge Discovery Perspective Limsoon Wong Institute for Infocomm Research Singapore.
Evolutionary Algorithms for Finding Optimal Gene Sets in Micro array Prediction. J. M. Deutsch Presented by: Shruti Sharma.
Computational Diagnostics A new research group at the Max Planck Institute for molecular Genetics, Berlin.
Whole Genome Approaches to Cancer 1. What other tumor is a given rare tumor most like? 2. Is tumor X likely to respond to drug Y?
Copyright  2004 limsoon wong A Practical Introduction to Bioinformatics Limsoon Wong Institute for Infocomm Research Lecture 3, May 2004 For written notes.
Enrollment and Monitoring Procedures for NCI Supported Clinical Trials Barry Anderson, MD, PhD Cancer Therapy Evaluation Program National Cancer Institute.
Prof. Yechiam Yemini (YY) Computer Science Department Columbia University (c)Copyrights; Yechiam Yemini; Lecture 2: Introduction to Paradigms 2.3.
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring T.R. Golub et al., Science 286, 531 (1999)
Copyright  2004 limsoon wong Using WEKA for Classification (without feature selection)
Copyright © 2004, 2005 by Jinyan Li and Limsoon Wong For written notes on this lecture, please read chapter 14 of The Practical Bioinformatician, CS2220:
Eigengenes as biological signatures Dr. Habil Zare, PhD PI of Oncinfo Lab Assistant Professor, Department of Computer Science Texas State University 5.
Copyright © 2004, 2005 by Jinyan Li and Limsoon Wong For written notes on this lecture, please read chapter 3 of The Practical Bioinformatician, CS2220:
Copyright © 2004 by Jinyan Li and Limsoon Wong Rule-Based Data Mining Methods for Classification Problems in Biomedical Domains Jinyan Li Limsoon Wong.
Copyright  2004 limsoon wong CS2220: Computation Foundation in Bioinformatics Limsoon Wong Institute for Infocomm Research Lecture slides for 13 January.
Solving the Fragmentation Problem of Decision Trees by Discovering Boundary Emerging Patterns Jinyan Li and Limsoon Wong Speaker: Sarah Chan CSIS DB Seminar.
Classification of tissues and samples 指導老師:藍清隆 演講者:張許恩、王人禾.
Classifiers!!! BCH364C/391L Systems Biology / Bioinformatics – Spring 2015 Edward Marcotte, Univ of Texas at Austin.
Show & Tell Limsoon Wong Kent Ridge Digital Labs Singapore Role of Bioinformatics in the Genomic Era.
Therapeutic Advances in Acute Myleoid Leukemia J Clin Oncol 29: (Volume 29. Number 5. February ) Samuel Aparicio, B.M., B.Ch., Ph.D., and.
Preliminary Results of a Multicenter Phase II Trial of 5-Day Decitabine as Front-Line Therapy for Elderly Patients with Acute Myeloid Leukemia (AML) Cashen.
An Artificial Intelligence Approach to Precision Oncology
Classifiers!!! BCH339N Systems Biology / Bioinformatics – Spring 2016
Classifiers!!! BCH364C/394P Systems Biology / Bioinformatics
Gene expression.
Molecular Classification of Cancer
Claudio Lottaz and Rainer Spang
Building better therapy for children with acute lymphoblastic leukemia
Computational Diagnostics
PCA, Clustering and Classification by Agnieszka S. Juncker
Volume 1, Issue 2, Pages (March 2002)
Molecular prognostication of liver cancer: End of the beginning
Figure 1. Identification of three tumour molecular subtypes in CIT and TCGA cohorts. We used CIT multi-omics data ( Figure 1. Identification of.
Claudio Lottaz and Rainer Spang
Presentation transcript:

Copyright  2003 limsoon wong Diagnosis of Childhood Acute Lymphoblastic Leukemia and Optimization of Risk-Benefit Ratio of Therapy Limsoon Wong Institute for Infocomm Research Singapore

Copyright  2003 limsoon wong Childhood ALL Heterogeneous Disease Major subtypes are –T-ALL –E2A-PBX1 –TEL-AML1 –MLL genome rearrangements –Hyperdiploid>50 –BCR-ABL

Copyright  2003 limsoon wong Childhood ALL Treatment Failure Overly intensive treatment leads to –Development of secondary cancers –Reduction of IQ Insufficiently intensive treatment leads to –Relapse

Copyright  2003 limsoon wong Childhood ALL Risk-Stratified Therapy Different subtypes respond differently to the same treatment intensity  Match patient to optimum treatment intensity for his subtype & prognosis BCR-ABL, MLL TEL-AML1, Hyperdiploid>50 T-ALLE2A-PBX1 Generally good-risk, lower intensity Generally high-risk, higher intensity

Copyright  2003 limsoon wong Childhood ALL Risk Assignment The major subtypes look similar Conventional diagnosis requires –Immunophenotyping –Cytogenetics –Molecular diagnostics

Copyright  2003 limsoon wong Mission Conventional risk assignment procedure requires difficult expensive tests and collective judgement of multiple specialists Generally available only in major advanced hospitals  Can we have a single-test easy-to-use platform instead?

Copyright  2003 limsoon wong Single-Test Platform of Microarray & Machine Learning

Copyright  2003 limsoon wong Overall Strategy Diagnosis of subtype Subtype- dependent prognosis Risk- stratified treatment intensity For each subtype, select genes to develop classification model for diagnosing that subtype For each subtype, select genes to develop prediction model for prognosis of that subtype

Copyright  2003 limsoon wong Childhood ALL Subtype Diagnosis by PCL Gene expression data collection Gene selection by  2 Classifier training by emerging pattern Classifier tuning (optional for some machine learning methods) Apply classifier for diagnosis of future cases by PCL

Copyright  2003 limsoon wong Childhood ALL Subtype Diagnosis Our Workflow A tree-structured diagnostic workflow was recommended by our doctor collaborator

Copyright  2003 limsoon wong Childhood ALL Subtype Diagnosis Training and Testing Sets

Copyright  2003 limsoon wong Childhood ALL Subtype Diagnosis Signal Selection Basic Idea Choose a signal w/ low intra-class distance Choose a signal w/ high inter-class distance

Copyright  2003 limsoon wong Childhood ALL Subtype Diagnosis Signal Selection by  2

Copyright  2003 limsoon wong Childhood ALL Subtype Diagnosis Emerging Patterns An emerging pattern is a set of conditions –usually involving several features –that most members of a class satisfy –but none or few of the other class satisfy A jumping emerging pattern is an emerging pattern that –some members of a class satisfy –but no members of the other class satisfy We use only jumping emerging patterns

Copyright  2003 limsoon wong Childhood ALL Subtype Diagnosis PCL: Prediction by Collective Likelihood

Copyright  2003 limsoon wong Childhood ALL Subtype Diagnosis Accuracy of PCL (vs. other classifiers) The classifiers are all applied to the 20 genes selected by  2 at each level of the tree

Copyright  2003 limsoon wong Multidimensional Scaling Plot Subtype Diagnosis

Copyright  2003 limsoon wong Multidimensional Scaling Plot Subtype-Dependent Prognosis Similar computational analysis was carried out to predict relapse and/or secondary AML in a subtype- specific manner >97% accuracy achieved

Copyright  2003 limsoon wong Childhood ALL Is there a new subtype? Hierarchical clustering of gene expression profiles reveals a novel subtype of childhood ALL

Copyright  2003 limsoon wong Childhood ALL Cure Rates in ASEAN Countries Conventional risk assignment procedure requires difficult expensive tests and collective judgement of multiple specialists  Not available in less advanced ASEAN countries

Copyright  2003 limsoon wong Childhood ALL Treatment Cost Treatment for childhood ALL over 2 yrs –Intermediate intensity: US$60k –Low intensity: US$36k –High intensity: US$72k Treatment for relapse: US$150k Cost for side-effects: Unquantified

Copyright  2003 limsoon wong Childhood ALL in ASEAN Counties Current Situation (2000 new cases/yr) Intermediate intensity conventionally applied in less advanced ASEAN countries  Over intensive for 50% of patients, thus more side effects  Under intensive for 10% of patients, thus more relapse  5-20% cure rates US$120m (US$60k * 2000) for intermediate intensity treatment US$30m (US$150k * 2000 * 10%) for relapse treatment Total US$150m/yr plus un-quantified costs for dealing with side effects

Copyright  2003 limsoon wong Childhood ALL in ASEAN Counties Using Our Platform (2000 new cases/yr) Low intensity applied to 50% of patients Intermediate intensity to 40% of patients High intensity to 10% of patients  Reduced side effects  Reduced relapse  75-80% cure rates US$36m (US$36k * 2000 * 50%) for low intensity US$48m (US$60k * 2000 * 40%) for intermediate intensity US$14.4m (US$72k * 2000 * 10%) for high intensity Total US$98.4m/yr  Save US$51.6m/yr

Copyright  2003 limsoon wong Acknowledgements